Merus N.V.: Merus Announces Financial Results for the First Quarter 2022 and Provides Business Update
- Zenocutuzumab clinical abstract selected for oral presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting- Company to host investor call on Sunday, June 5 at 6:00 p.m.